English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

We report a case, undescribed until now, of a renal transplant patient who developed a malignant hypertension after change sirolimus by tacrolimus. Also presented thrombocytopenia and anemia as a first orientation could suggest a hemolytic uremic síndrome, but subsequent events confirmed that everythins was due to malignant hypertension. Clara Ma Moriana Domínguez, Francisco José Borrego Utiel, María Pilar Pérez del Barrio, Josefa Borrego Hinojosa. Servicio de Nefrología. Complejo Hospitalario de Jaén, España. Enviado: 10-11-2016 Revisado: 02-02-2017 Aceptado: 03-03-2017 Clara Ma Moriana Domínguez. D. Postal: C/ Santo Reino, No5, 5o, CP 23003, Jaén. email: claricemd@hotmail.com. Teléfono: 610766606 Palabras clave: Hipertensión arterial maligna, Trasplante renal.

Malignant hypertension and thrombopenia in renal transplant after switching from sirolimus to tacrolimus